{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:00:10Z","timestamp":1787677210766,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009558","name":"University Natural Science Research Project of Anhui Province","doi-asserted-by":"publisher","award":["2023AH040380"],"award-info":[{"award-number":["2023AH040380"]}],"id":[{"id":"10.13039\/501100009558","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Cultivation Program of The Second Affiliated Hospital of Anhui Medical University","award":["2021LCYB08"],"award-info":[{"award-number":["2021LCYB08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-025-06368-7","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T12:01:07Z","timestamp":1764849667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["157Gd-DHK: enhancing targeted gadolinium neutron capture for pancreatic adenocarcinoma"],"prefix":"10.1007","volume":"152","author":[{"given":"Liang","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"7","key":"6368_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2174\/138945009788680374","volume":"10","author":"A Bandyopadhyay","year":"2009","unstructured":"Bandyopadhyay A, Raghavan S (2009) Defining the role of integrin alphavbeta6 in cancer. Curr Drug Targets 10(7):645\u2013652","journal-title":"Curr Drug Targets"},{"key":"6368_CR2","volume":"38","author":"RF Barth","year":"2018","unstructured":"Barth RF, Mi P, Yang W (2018) Boron delivery agents for neutron capture therapy of cancer. Cancer Commun 38:35","journal-title":"Cancer Commun"},{"key":"6368_CR3","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/cac2.12582","volume":"44","author":"RF Barth","year":"2024","unstructured":"Barth RF, Gupta N, Kawabata S (2024) Evaluation of sodium borocaptate (BSH) and boronophenylalanine (BPA) as boron delivery agents for neutron capture therapy (NCT) of cancer: an update and a guide for the future clinical evaluation of new boron delivery agents for NCT. Cancer Commun 44:893\u2013909","journal-title":"Cancer Commun"},{"issue":"3","key":"6368_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1148\/radiology.166.3.3340763","volume":"166","author":"JC Bousquet","year":"1988","unstructured":"Bousquet JC, Saini S, Stark DD, Hahn PF, Nigam M, Wittenberg J, Ferrucci JT Jr (1988) Gd-DOTA: characterization of a new paramagnetic complex. Radiology 166(3):693\u2013698","journal-title":"Radiology"},{"issue":"6","key":"6368_CR5","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"6368_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier JS, Cheresh DA (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10(1):9\u201322","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"6368_CR8","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1007\/s00259-020-04975-9","volume":"48","author":"T Ebenhan","year":"2021","unstructured":"Ebenhan T, Kleynhans J, Zeevaart JR, Jeong JM, Sathekge M (2021) Non-oncological applications of RGD-based single-photon emission tomography and positron emission tomography agents. Eur J Nucl Med Mol Imaging 48(5):1414\u20131433","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"6368_CR9","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1021\/acsomega.8b00035","volume":"3","author":"SF F\u00e4rber","year":"2018","unstructured":"F\u00e4rber SF, Wurzer A, Reichart F, Beck R, Kessler H, Wester HJ, Notni J (2018) Therapeutic radiopharmaceuticals targeting integrin \u03b1v\u03b26. ACS Omega 3(2):2428\u20132436","journal-title":"ACS Omega"},{"issue":"5","key":"6368_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.rpor.2018.07.002","volume":"23","author":"B Farhood","year":"2018","unstructured":"Farhood B, Samadian H, Ghorbani M, Zakariaee SS, Knaup C (2018) Physical, dosimetric and clinical aspects and delivery systems in neutron capture therapy. Rep Pract Oncol Radiother 23(5):462\u2013473","journal-title":"Rep Pract Oncol Radiother"},{"key":"6368_CR11","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1021\/acsomega.1c06603","volume":"7","author":"SL Ho","year":"2022","unstructured":"Ho SL, Yue H, Tegafaw T, Ahmad MY, Liu S, Nam SW, Chang Y, Lee GH (2022) Gadolinium neutron capture therapy (GdNCT) agents from molecular to nano: current status and perspectives. ACS Omega 7:2533\u20132553","journal-title":"ACS Omega"},{"issue":"6","key":"6368_CR12","first-page":"687","volume":"25","author":"CH Ju","year":"2010","unstructured":"Ju CH, Jeong JM, Lee YS, Kim YJ, Lee BC, Lee DS, Chung JK, Lee MC, Jeong SY (2010) Development of a 1\u2077\u2077Lu-labeled RGD derivative for targeting angiogenesis. Cancer Biother Radiopharm 25(6):687\u2013691","journal-title":"Cancer Biother Radiopharm"},{"issue":"2","key":"6368_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00261-017-1373-3","volume":"43","author":"EJ Koay","year":"2018","unstructured":"Koay EJ, Hall W, Park PC, Erickson B, Herman JM (2018) The role of imaging in the clinical practice of radiation oncology for pancreatic cancer. Abdom Radiol 43(2):393\u2013403","journal-title":"Abdom Radiol"},{"key":"6368_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.biocel.2018.04.013","volume":"99","author":"L Koivisto","year":"2018","unstructured":"Koivisto L, Bi J, H\u00e4kkinen L, Larjava H (2018) Integrin \u03b1v\u03b26: structure, function and role in health and disease. Int J Biochem Cell Biol 99:186\u2013196","journal-title":"Int J Biochem Cell Biol"},{"key":"6368_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41467-023-35935-0","volume":"14","author":"YH Lai","year":"2023","unstructured":"Lai YH, Su CY, Cheng HW, Chu CY, Jeng LB, Chiang CS, Shyu WC, Chen SY (2023) Stem cell-nanomedicine system as a theranostic bio-gadolinium agent for targeted neutron capture cancer therapy. Nat Commun 14:285","journal-title":"Nat Commun"},{"issue":"6","key":"6368_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2967\/jnumed.113.132969","volume":"55","author":"Z Liu","year":"2014","unstructured":"Liu Z, Liu H, Ma T, Sun X, Shi J, Jia B, Sun Y, Zhan J, Zhang H, Zhu Z, Wang F (2014) Integrin \u03b1v\u03b2\u2086-targeted SPECT imaging for pancreatic cancer detection. J Nucl Med 55(6):989\u2013994","journal-title":"J Nucl Med"},{"issue":"7","key":"6368_CR17","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.7150\/thno.22172","volume":"8","author":"Y Liu","year":"2018","unstructured":"Liu Y, Zhang P, Li F, Jin X, Li J, Chen W, Li Q (2018) Metal-based nanoenhancers for future radiotherapy: radiosensitizing and synergistic effects on tumor cells. Theranostics 8(7):1824\u20131849","journal-title":"Theranostics"},{"issue":"35","key":"6368_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202400954","volume":"20","author":"J Liu","year":"2024","unstructured":"Liu J, Wu J, Chen T, Yang B, Liu X, Xi J, Zhang Z, Gao Y, Li Z (2024) Enhancing x-ray sensitization with multifunctional nanoparticles. Small 20(35):e2400954","journal-title":"Small"},{"issue":"6","key":"6368_CR19","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1021\/acsnano.5b00532","volume":"9","author":"P Mi","year":"2015","unstructured":"Mi P, Dewi N, Yanagie H, Kokuryo D, Suzuki M, Sakurai Y, Li Y, Aoki I, Ono K, Takahashi H, Cabral H, Nishiyama N, Kataoka K (2015) Hybrid calcium phosphate-polymeric micelles incorporating gadolinium chelates for imaging-guided gadolinium neutron capture tumor therapy. ACS Nano 9(6):5913\u20135921","journal-title":"ACS Nano"},{"issue":"9","key":"6368_CR20","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/0360-3016(87)90242-2","volume":"13","author":"RW Miller","year":"1987","unstructured":"Miller RW, DeGraff W, Mitchell JB, Kinsella TJ (1987) Photon activation therapy (PAT). Int J Radiat Oncol Biol Phys 13(9):1429","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"6368_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/cancers9090116","volume":"9","author":"M Nieberler","year":"2017","unstructured":"Nieberler M, Reuning U, Reichart F, Notni J, Wester HJ, Schwaiger M, Weinm\u00fcller M, R\u00e4der A, Steiger K, Kessler H (2017) Exploring the role of RGD-recognizing integrins in cancer. Cancers (Basel) 9(9):116","journal-title":"Cancers (Basel)"},{"key":"6368_CR22","doi-asserted-by":"publisher","first-page":"6311","DOI":"10.1021\/acs.molpharmaceut.3c00726","volume":"20","author":"S Okada","year":"2023","unstructured":"Okada S, Nishimura K, Ainaya Q, Shiraishi K, Anufriev SA, Sivaev IB, Sakurai Y, Suzuki M, Yokoyama M, Nakamura H (2023) Development of a Gadolinium-Boron-conjugated albumin for MRI-guided neutron capture therapy. Mol Pharm 20:6311\u20136318","journal-title":"Mol Pharm"},{"issue":"2","key":"6368_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.canlet.2003.08.011","volume":"202","author":"T Oyama","year":"2003","unstructured":"Oyama T, Sykes KF, Samli KN, Minna JD, Johnston SA, Brown KC (2003) Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents. Cancer Lett 202(2):219\u2013230","journal-title":"Cancer Lett"},{"issue":"4","key":"6368_CR24","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s00259-021-05559-x","volume":"49","author":"NG Quigley","year":"2022","unstructured":"Quigley NG, Steiger K, Hober\u00fcck S, Czech N, Zierke MA, Kossatz S, Pretze M, Richter F, Weichert W, Pox C, Kotzerke J, Notni J (2022) PET\/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the \u201cCancer Integrin\u201d \u03b1v\u03b26 with Ga-68-Trivehexin. Eur J Nucl Med Mol Imaging 49(4):1136\u20131147","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"6368_CR25","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913\u20132921","journal-title":"Cancer Res"},{"issue":"3","key":"6368_CR26","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/path.5320","volume":"249","author":"CS Reader","year":"2019","unstructured":"Reader CS, Vallath S, Steele CW, Haider S, Brentnall A, Desai A, Moore KM, Jamieson NB, Chang D, Bailey P, Scarpa A, Lawlor R, Chelala C, Keyse SM, Biankin A, Morton JP, Evans TJ, Barry ST, Sansom OJ, Kocher HM, Marshall JF (2019) The integrin \u03b1v\u03b26 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. J Pathol 249(3):332\u2013342","journal-title":"J Pathol"},{"issue":"1","key":"6368_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0939-6411(01)00198-9","volume":"53","author":"F Shikata","year":"2002","unstructured":"Shikata F, Tokumitsu H, Ichikawa H, Fukumori Y (2002) In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer. Eur J Pharm Biopharm 53(1):57\u201363","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"6368_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1365-2559.2004.01919.x","volume":"45","author":"B Sipos","year":"2004","unstructured":"Sipos B, Hahn D, Carceller A, Piulats J, Hedderich J, Kalthoff H, Goodman SL, Kosmahl M, Kl\u00f6ppel G (2004) Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. Histopathology 45(3):226\u2013236","journal-title":"Histopathology"},{"issue":"3","key":"6368_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nrclinonc.2009.236","volume":"7","author":"A Stathis","year":"2010","unstructured":"Stathis A, Moore MJ (2010) Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 7(3):163\u2013172","journal-title":"Nat Rev Clin Oncol"},{"key":"6368_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.788770","volume":"12","author":"S Wang","year":"2022","unstructured":"Wang S, Zhang Z, Miao L, Li Y (2022) Boron neutron capture therapy: current status and challenges. Front Oncol 12:788770","journal-title":"Front Oncol"},{"issue":"2","key":"6368_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4329\/wjr.v9.i2.63","volume":"9","author":"XJ Zheng","year":"2017","unstructured":"Zheng XJ, Chow JC (2017) Radiation dose enhancement in skin therapy with nanoparticle addition: a Monte Carlo study on kilovoltage photon and megavoltage electron beams. World J Radiol 9(2):63\u201371","journal-title":"World J Radiol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06368-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06368-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06368-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T12:01:08Z","timestamp":1764849668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06368-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["6368"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06368-7","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"26 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experimental procedures were conducted in accordance with the guidelines of the Institutional Animal Experimentation Ethics Committee of Anhui Medical University under Grant No. LLSC20160228.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"5"}}